Skip to main content
Equibles
KIMS 729.6000 INR +0.31%
KIMS · Krishna Institute of Medical Sciences Limited

Use KIMS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KIMS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
729.60 INR +2.25 (+0.31%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 9897 Avg daily vol (3M) 74.63K
All webcasts

Earnings call · FY2026 Q4

Krishna Institute of Medical Sciences Limited (KIMS) Q4 2026 Earnings Call

Concluded May 12, 2026
May 12, 2026
Period
FY2026 Q4
Runtime
—
Sources
0 artifacts
Revenue 10.75B INR +34.8% YoY
Diluted EPS 1.06 INR/shares -58.3% YoY
Net income 425.00M INR -58.3% YoY

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. Event details are collected in one workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Company webcastOpen the original investor-relations page
Full-screen source Call document

KIMS alerts

Krishna Institute of Medical Sciences Limited

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →

Embed Krishna Institute of Medical Sciences Limited earnings calls on your site

Pick a widget, match your page, then paste the code where it should appear.

Widget
Theme
Accent color Pro

Match your site's colors with Pro. The Equibles credit stays on every plan.

Embed code 

                    
The widget credits Equibles and keeps the link below it on every plan.

                

            


            

                Preview